Article
Potential therapeutic targets for Mpox: the evidence to date
3 Jun 2023
Abstract excerpt
INTRODUCTION: The global Mpox (MPX) disease outbreak caused by the Mpox virus (MPXV) in 2022 alarmed the World Health Organization (WHO) and health regulation agencies of individual countries leading to the declaration of MPX as a Public Health Emergency. Owing to the genetic similarities between smallpox-causing poxvirus and MPXV, vaccine JYNNEOS, and anti-smallpox drugs Brincidofovir and Tecovirimat were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
